Effect of Zink Sulphate in Pneumonia

Zink supplement effect in Community Acquired Pneumonia Outcome in hospitalized Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015013120882N1

Enrollment

Registered

2015-04-04

Start date

2013-07-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia. Pneumonia, unspecified

Interventions

Intervention 1: Intervention Group: Zinc Sulphate 110 mg Capsules q12h for 4 days. Intervention 2: Control Group: Placebo Capsules Same as Zinc Sulphate 110 mg Capsules q12h for 4 days.

Treatment - Drugs

Placebo

Control Group: Placebo Capsules Same as Zinc Sulphate 110 mg Capsules q12h for 4 days

Intervention Group: Zinc Sulphate 110 mg Capsules q12h for 4 days

Eligibility

Sex/Gender

All

Age

50 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Community Acquired Pneumonia; admitted patient; older than 50 years; Exclusion Criteria: Severe neurologic disease; Admission more than 25 days; Death due to Other Causes;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration Of Admission. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: records.;Duration Of Tachypnea. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: Examination.;Duration Of Tachycardia. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: Examination.;Blood Pressure day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Barometer.;Duration Of Fever. Timepoint: Time of Admission, 6hours Later, 12hours Later, 18hours Later, Time of Discharge. Method of measurement: Thermometer.;Duration Of Hypoxia. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: Electronic Pulseoxymeter.;GCS Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Examination.;WBC Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Laboratory.;ESR Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Laboratory.;Platelet Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Laboratory.	—

Measure

Time frame

Duration Of Admission. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: records.;Duration Of Tachypnea. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: Examination.;Duration Of Tachycardia. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: Examination.;Blood Pressure day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Barometer.;Duration Of Fever. Timepoint: Time of Admission, 6hours Later, 12hours Later, 18hours Later, Time of Discharge. Method of measurement: Thermometer.;Duration Of Hypoxia. Timepoint: Day1, Day2, Day3, ... Day of discharge. Method of measurement: Electronic Pulseoxymeter.;GCS Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Examination.;WBC Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Laboratory.;ESR Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Laboratory.;Platelet Day 4. Timepoint: Time of Admission, 4th Day. Method of measurement: Laboratory.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Saeed Sharafi

Qazvin University of Medical Sciences

saeedsharafi@yahoo.com+98 28 3332 6032

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026